Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Total Liabilities (2020 - 2024)

RAPT Therapeutics' Total Liabilities history spans 5 years, with the latest figure at $13.0 million for Q3 2024.

  • For Q3 2024, Total Liabilities fell 51.86% year-over-year to $13.0 million; the TTM value through Sep 2024 reached $13.0 million, down 51.86%, while the annual FY2023 figure was $26.3 million, 24.95% up from the prior year.
  • Total Liabilities for Q3 2024 was $13.0 million at RAPT Therapeutics, down from $18.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $27.9 million in Q1 2023 and bottomed at $12.3 million in Q4 2021.
  • The 5-year median for Total Liabilities is $19.0 million (2020), against an average of $19.2 million.
  • The largest annual shift saw Total Liabilities soared 71.7% in 2022 before it plummeted 51.86% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $14.8 million in 2020, then fell by 17.13% to $12.3 million in 2021, then soared by 71.7% to $21.0 million in 2022, then increased by 24.95% to $26.3 million in 2023, then crashed by 50.71% to $13.0 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Total Liabilities are $13.0 million (Q3 2024), $18.0 million (Q2 2024), and $25.0 million (Q1 2024).